Cargando…
The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995–2015
Stroke is a brain damage caused by a loss of blood supply to a portion of the brain, which requires prompt and effective treatment. The current pharmacotherapy for ischemic stroke primarily relies on thrombolysis using recombinant tissue plasminogen activators (rt-PAs) to breakdown blood clots. Neur...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071630/ https://www.ncbi.nlm.nih.gov/pubmed/27818918 http://dx.doi.org/10.1016/j.apsb.2016.06.013 |